Medicare Enrolled

Dr. Rachel Tedesco, NP

Physician Assistant · Whiteville, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
44 MCNEILL PLZ, Whiteville, NC 28472
9106414095
In practice since 2019 (6 years)
NPI: 1063056687 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tedesco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tedesco? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tedesco

Dr. Rachel Tedesco is a physician assistant in Whiteville, NC, with 6 years of NPI registration. Based on federal Medicare data, Dr. Tedesco performed 254,358 Medicare services across 2,134 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tedesco received a total of $1,767 from 16 pharmaceutical and/or device companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tedesco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice ▲ Top 0% volume in NC $1,767 industry payments

Medicare Practice Summary

Medicare Utilization ↗
254,358
Medicare services
Top 0% in NC for physician assistant
2,134
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42,393 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
53,700 $17 $81
Romosozumab injection (Evenity) for osteoporosis 49,770 $8 $32
Denosumab injection (Prolia/Xgeva) 33,600 $18 $94
Inclisiran injection (Leqvio) for cholesterol 30,388 $9 $63
Ocrelizumab infusion (Ocrevus) for MS 15,900 $46 $149
Omalizumab injection (Xolair) for asthma/allergy 13,995 $30 $100
Injection, mepolizumab, 1 mg 13,400 $23 $80
Tezepelumab injection, 1 mg
An injection of tezepelumab-ekko, a medication administered in 1 mg doses.
12,390 $14 $66
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
10,140 $36 $194
Injection, tildrakizumab, 1 mg 7,600 $109 $491
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
5,620 $26 $280
Injection, benralizumab, 1 mg 3,810 $132 $548
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
1,497 $9 $52
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
861 $39 $274
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
721 $13 $60
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
222 $77 $310
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
216 $17 $80
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
192 $10 $50
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
114 $4 $52
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
95 $6 $168
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
67 $1 $10
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
34 $44 $125
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
26 $0 $6
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.3% high complexity
65.7% medium
0.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,767
Total received (2022-2024)
Avg $589/year across 3 years
Top 18% in NC for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
24
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,767 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$817
2023
$717
2022
$233

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$132
Agios Pharmaceuticals, Inc.
$130
COLOPLAST CORP
$123
Amgen Inc.
$114
AstraZeneca Pharmaceuticals LP
$112
Novo Nordisk Inc
$111
Alexion Pharmaceuticals, Inc.
$45
Daiichi Sankyo Inc.
$28
ARGENX US, INC.
$22
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2022-2024) ›
GlaxoSmithKline, LLC.
$278
AstraZeneca Pharmaceuticals LP
$237
Neurocrine Biosciences, Inc.
$132
Agios Pharmaceuticals, Inc.
$130
COLOPLAST CORP
$123
Horizon Therapeutics plc
$121
Daiichi Sankyo Inc.
$120
IDORSIA PHARMACEUTICALS US INC
$117
Amgen Inc.
$114
Novo Nordisk Inc
$111
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$98
GENZYME CORPORATION
$66
Alexion Pharmaceuticals, Inc.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$27
ABBVIE INC.
$26
ARGENX US, INC.
$22
Top 3 companies account for 36.6% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · BENLYSTA · FABRAZYME · FARXIGA · INJECTAFER · KRYSTEXXA · LifeVest · NUCALA · PYRUKYND · QUVIVIQ · SKYRIZI · Titan · ULTOMIRIS · VYVGART HYTRULO · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a physician assistant in Whiteville?
Compare physician assistants in the Whiteville area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
26
Per 100K population
51.5
County median income
$48,184
Nearest hospital
COLUMBUS REGIONAL HEALTHCARE SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tedesco is a mixed practice specialist, with above-average Medicare volume (top 0% in NC), with low-engagement industry engagement in the top 18% of NC peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tedesco experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Tedesco performed 53,700 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tedesco receive payments from pharmaceutical companies?
Yes. Dr. Tedesco received a total of $1,767 from 16 companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tedesco's costs compare to other physician assistants in Whiteville?
Dr. Tedesco's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tedesco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →